BHAVADHARANI, S. et al. 2025. ATORVASTATIN IN CEREBRAL CAVERNOUS MALFORMATION: ELUCIDATING ROCK INHIBITION AND LIPID-LOWERING MECHANISMS FOR THERAPEUTIC REPURPOSING. TPM – Testing, Psychometrics, Methodology in Applied Psychology. 32, S1 (2025): Posted 12 May (Aug. 2025), 396–399.